METANOTITIA

Founded in 2018, Metanotitia Inc. is dedicated to transform treatment decisions and outcomes by delivering clinically actionable diagnostics, specializing in offering one-stop solutions by leveraging the power of metabolomics. The founding team transferred the top-tier technology and more than 20 years of scientific research experience in metabolomics from Germany to Shenzhen, China, and is committed to building and upgrading theProfMet metabolomics R&D platform. We are dedicated to combine high-quality human metabolome data with AI advances to answer clinical questions... The result of gene-environment interaction is ultimately reflected in our physical state, known as phenotypes, with metabolites being the most closely related. We are committed to solving major medical challenges across the healthcare continuum, such as early diagnosis, high-risk screening, and treatment monitoring, through comprehensive and integrated analysis of these small molecules in blood. The metabolic models..

Also known as: Metanotitia Inc.